Advertisement

Topics

20152023 World Glucagon Like Peptide1 GLP1 Agonists Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 15122017] Prices from USD $2800

08:42 EST 22 Jan 2018 | BioPortfolio Reports

Summary

Glucagon like peptide1 GLP1 agonists is the agonists of the GLP1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Market Segment as follows:

By Region / Countries

North America U.S., Canada, Mexico

Europe Germany, U.K., France, Italy, Russia, Spain etc

South America Brazil, Argentina etc

Middle East Africa Saudi Arabia, South Africa etc

By Type

Exenatied

Liraglutide

Lixisenatide

Albiglutide

Dulaglutide

By EndUser / Application

Hospital

Pharmacy

Others

By Company

Novo Nordisk

AstraZeneca

Eli Lily

GSK

Sanofi

BristolMyers Squibb

Amylin

Original Article: 20152023 World Glucagon Like Peptide1 GLP1 Agonists Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 15122017] Prices from USD $2800

NEXT ARTICLE

More From BioPortfolio on "20152023 World Glucagon Like Peptide1 GLP1 Agonists Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 15122017] Prices from USD $2800"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...